{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:07:35Z","timestamp":1774616855398,"version":"3.50.1"},"reference-count":67,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","revespcardiol.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.rec.2023.06.014","type":"journal-article","created":{"date-parts":[[2023,9,9]],"date-time":"2023-09-09T19:13:23Z","timestamp":1694286803000},"page":"79-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Monitoring cardiac amyloidosis with multimodality imaging"],"prefix":"10.1016","volume":"77","author":[{"given":"Neasa","family":"Starr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Martinez-Naharro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rec.2023.06.014_bib0340","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1016\/S0140-6736(15)01274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet."},{"key":"10.1016\/j.rec.2023.06.014_bib0345","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1001\/jama.2020.5493","article-title":"Systemic Amyloidosis Recognition, Prognosis, and Therapy","volume":"324","author":"Gertz","year":"2020","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2023.06.014_bib0350","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nrneph.2013.171","article-title":"Pathophysiology and treatment of systemic amyloidosis","volume":"9","author":"Gillmore","year":"2013","journal-title":"Nat Rev Nephrol."},{"key":"10.1016\/j.rec.2023.06.014_bib0355","doi-asserted-by":"crossref","first-page":"15661","DOI":"10.1038\/s41598-017-15424-3","article-title":"Proteotoxicity in cardiac amyloidosis: amyloidogenic light chains affect the levels of intracellular proteins in human heart cells","volume":"7","author":"Imperlini","year":"2017","journal-title":"Sci Rep."},{"key":"10.1016\/j.rec.2023.06.014_bib0360","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jaccao.2022.08.009","article-title":"AL Amyloidosis for Cardiologists: Awareness, Diagnosis, and Future Prospects: JACC: CardioOncology State-of-the-Art Review","volume":"4","author":"Wechalekar","year":"2022","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.rec.2023.06.014_bib0365","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/ejh.13681","article-title":"Impact of time to diagnosis on Mayo stages, treatment outcome, and survival in patients with AL amyloidosis and cardiac involvement","volume":"107","author":"Oubari","year":"2021","journal-title":"Eur J Haematol."},{"key":"10.1016\/j.rec.2023.06.014_bib0370","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1182\/blood.2019000834","article-title":"A prospective observational study of 915 patients with systemic AL amyloidosis treated with upfront bortezomib","volume":"134","author":"Manwani","year":"2019","journal-title":"Blood."},{"key":"10.1016\/j.rec.2023.06.014_bib0375","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1002\/ejhf.2646","article-title":"Sex differences among patients with transthyretin amyloid cardiomyopathy\u00a0\u2013\u00a0from diagnosis to prognosis","volume":"24","author":"Patel","year":"2022","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2023.06.014_bib0380","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/ejhf.2776","article-title":"Prevalence, characteristics and outcomes of older patients with hereditary versus wild-type transthyretin amyloid cardiomyopathy","volume":"25","author":"Porcari","year":"2023","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2023.06.014_bib0385","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s40259-023-00577-7","article-title":"RNA Targeting and Gene Editing Strategies for Transthyretin Amyloidosis","volume":"37","author":"Ioannou","year":"2023","journal-title":"BioDrugs."},{"key":"10.1016\/j.rec.2023.06.014_bib0390","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa2107454","article-title":"CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis","volume":"385","author":"Gillmore","year":"2021","journal-title":"New Engl J Med."},{"key":"10.1016\/j.rec.2023.06.014_bib0395","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jcmg.2019.10.011","article-title":"Multiparametric Echocardiography Scores for the Diagnosis of Cardiac Amyloidosis","volume":"13","author":"Boldrini","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0400","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1016\/j.jcmg.2019.07.015","article-title":"How to Image Cardiac Amyloidosis","volume":"13","author":"Dorbala","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0405","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1161\/CIRCULATIONAHA.113.006242","article-title":"Left Ventricular Structure and Function in Transthyretin-Related Versus Light-Chain Cardiac Amyloidosis","volume":"129","author":"Quarta","year":"2014","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.014_bib0410","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10741-014-9466-3","article-title":"Echocardiography in cardiac amyloidosis","volume":"20","author":"Falk","year":"2015","journal-title":"Heart Fail Rev."},{"key":"10.1016\/j.rec.2023.06.014_bib0415","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajh.20381","article-title":"Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis","volume":"79","author":"Gertz","year":"2005","journal-title":"Am J Hematol."},{"key":"10.1016\/j.rec.2023.06.014_bib0420","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/j.jcmg.2018.07.007","article-title":"Relative Left Ventricular Apical Sparing of Longitudinal Strain in Cardiac Amyloidosis: Is it Just Amyloid Infiltration?","volume":"12","author":"Rapezzi","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0425","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/ehjci\/jew298","article-title":"Longitudinal systolic strain, cardiac function improvement, and survival following treatment of light-chain (AL) cardiac amyloidosis","volume":"18","author":"Salinaro","year":"2017","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0430","doi-asserted-by":"crossref","first-page":"3420","DOI":"10.1182\/blood-2012-12-473066","article-title":"A European collaborative study of treatment outcomes in 346 patients with cardiac stage III AL amyloidosis","volume":"121","author":"Wechalekar","year":"2013","journal-title":"Blood."},{"key":"10.1016\/j.rec.2023.06.014_bib0435","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jaccao.2020.05.012","article-title":"Incremental Value of Global Longitudinal Strain for Predicting Survival in Patients With Advanced AL Amyloidosis","volume":"2","author":"Lee Chuy","year":"2020","journal-title":"JACC CardioOncol."},{"key":"10.1016\/j.rec.2023.06.014_bib0440","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/eurheartj\/ehab507","article-title":"Longitudinal strain is an independent predictor of survival and response to therapy in patients with systemic AL amyloidosis","volume":"43","author":"Cohen","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.06.014_bib0445","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/eurheartj\/ehz905","article-title":"Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis","volume":"41","author":"Chacko","year":"2020","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.06.014_bib0450","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.cardfail.2018.07.001","article-title":"Myocardial Contraction Fraction by M-Mode Echocardiography Is Superior to Ejection Fraction in Predicting Mortality in Transthyretin Amyloidosis","volume":"24","author":"RUBIN","year":"2018","journal-title":"J Card Fail."},{"key":"10.1016\/j.rec.2023.06.014_bib0455","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.jacc.2017.05.053","article-title":"Magnetic Resonance in Transthyretin\u00a0Cardiac Amyloidosis","volume":"70","author":"Martinez-Naharro","year":"2017","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.06.014_bib0460","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1161\/CIRCULATIONAHA.115.016567","article-title":"Prognostic Value of Late Gadolinium Enhancement Cardiovascular Magnetic Resonance in Cardiac Amyloidosis","volume":"132","author":"Fontana","year":"2015","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.014_bib0465","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S0002-9149(97)00400-1","article-title":"Right ventricular dilation in primary amyloidosis: an independent predictor of survival","volume":"80","author":"Patel","year":"1997","journal-title":"Am J Cardiol."},{"key":"10.1016\/j.rec.2023.06.014_bib0470","doi-asserted-by":"crossref","first-page":"4722","DOI":"10.1093\/eurheartj\/ehac363","article-title":"Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment","volume":"43","author":"Martinez-Naharro","year":"2022","journal-title":"Eur Heart J."},{"key":"10.1016\/j.rec.2023.06.014_bib0475","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.1016\/j.jacc.2018.03.536","article-title":"Myocardial Edema and Prognosis in\u00a0Amyloidosis","volume":"71","author":"Kotecha","year":"2018","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.06.014_bib0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2023.02.019","article-title":"Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0485","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41569-020-0334-7","article-title":"Diagnostic imaging of cardiac amyloidosis","volume":"17","author":"Martinez-Naharro","year":"2020","journal-title":"Nat Rev Cardiol."},{"key":"10.1016\/j.rec.2023.06.014_bib0490","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1161\/CIRCIMAGING.112.978627","article-title":"Quantification of myocardial extracellular volume fraction in systemic AL amyloidosis: an equilibrium contrast cardiovascular magnetic resonance study","volume":"6","author":"Banypersad","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0495","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jcmg.2018.02.006","article-title":"Native T1 and Extracellular Volume in\u00a0Transthyretin Amyloidosis","volume":"12","author":"Martinez-Naharro","year":"2019","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0500","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jcmg.2013.10.008","article-title":"Native T1 Mapping in Transthyretin Amyloidosis","volume":"7","author":"Fontana","year":"2014","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0505","doi-asserted-by":"crossref","first-page":"98","DOI":"10.3390\/cardiogenetics11030011","article-title":"Biventricular Strain Imaging with Cardiac MRI in Genotyped and Histology Validated Amyloid Cardiomyopathy","volume":"11","author":"Reddy","year":"2021","journal-title":"Cardiogenetics."},{"key":"10.1016\/j.rec.2023.06.014_bib0510","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99m Tc-Pyrophosphate Scintigraphy for Differentiating Light-Chain Cardiac Amyloidosis From the Transthyretin-Related Familial and Senile Cardiac Amyloidoses","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0515","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy Diagnosis of Cardiac Transthyretin Amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.014_bib0520","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.jacc.2005.05.073","article-title":"Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy","volume":"46","author":"Perugini","year":"2005","journal-title":"J Am Coll Cardiol."},{"key":"10.1016\/j.rec.2023.06.014_bib0525","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s12350-019-01760-6","article-title":"ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2\u2014evidence base and standardized methods of imaging","volume":"26","author":"Dorbala","year":"2019","journal-title":"J Nucl Cardiol."},{"key":"10.1016\/j.rec.2023.06.014_bib0530","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1093\/ehjci\/jeu107","article-title":"Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis","volume":"15","author":"Hutt","year":"2014","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0535","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1093\/ehjci\/jeab095","article-title":"99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis","volume":"22","author":"Quarta","year":"2021","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0540","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.jcmg.2022.07.008","article-title":"Multi-Imaging Characterization of Cardiac Phenotype in Different Types\u00a0of\u00a0Amyloidosis","volume":"16","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0545","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.jcmg.2020.03.020","article-title":"DPD Quantification in Cardiac\u00a0Amyloidosis: A Novel Imaging Biomarker","volume":"13","author":"Scully","year":"2020","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0550","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac transthyretin amyloidosis","volume":"26","author":"Singh","year":"2019","journal-title":"J Nucl Cardiol."},{"key":"10.1016\/j.rec.2023.06.014_bib0555","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/j.jcmg.2022.08.006","article-title":"Extracellular Volume Fraction by Computed Tomography Predicts Long-Term Prognosis Among Patients\u00a0With Cardiac Amyloidosis","volume":"15","author":"Gama","year":"2022","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0560","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.rec.2023.06.014_bib0565","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen Treatment for Patients with Hereditary Transthyretin Amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Eng J Med."},{"key":"10.1016\/j.rec.2023.06.014_bib0570","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1080\/13506120600960882","article-title":"Orally administered diflunisal stabilizes transthyretin against dissociation required for amyloidogenesis","volume":"13","author":"Sekijima","year":"2006","journal-title":"Amyloid."},{"key":"10.1016\/j.rec.2023.06.014_bib0575","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1001\/jama.2013.283815","article-title":"Repurposing diflunisal for familial amyloid polyneuropathy: a randomized clinical trial","volume":"310","author":"Berk","year":"2013","journal-title":"JAMA."},{"key":"10.1016\/j.rec.2023.06.014_bib0580","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/13506129.2021.2000388","article-title":"Diflunisal treatment is associated with improved survival for patients with early stage wild-type transthyretin (ATTR) amyloid cardiomyopathy: the Boston University Amyloidosis Center experience","volume":"29","author":"Siddiqi","year":"2022","journal-title":"Amyloid."},{"key":"10.1016\/j.rec.2023.06.014_bib0585","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis Treatment for Patients with Transthyretin Amyloid Cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Eng J Med."},{"key":"10.1016\/j.rec.2023.06.014_bib0590","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1093\/ehjci\/jeac049","article-title":"Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis","volume":"23","author":"Giblin","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0595","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/CIRCULATIONAHA.118.035831","article-title":"Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients with Hereditary Transthyretin-Mediated Amyloidosis: Analysis of the APOLLO Study","volume":"139","author":"Solomon","year":"2019","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.014_bib0600","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jcmg.2020.07.043","article-title":"Reduction in CMR Derived Extracellular Volume With Patisiran Indicates Cardiac Amyloid Regression","volume":"14","author":"Fontana","year":"2021","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0605","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jcmg.2017.02.012","article-title":"CMR-Verified Regression of Cardiac AL Amyloid After Chemotherapy","volume":"11","author":"Martinez-Naharro","year":"2018","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0610","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcmg.2023.02.019","article-title":"Tracking Multiorgan Treatment Response in Systemic AL-Amyloidosis With Cardiac Magnetic Resonance Derived Extracellular Volume Mapping","author":"Ioannou","year":"2023","journal-title":"JACC Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0615","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1002\/ejhf.2198","article-title":"Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy","volume":"23","author":"Garcia-Pavia","year":"2021","journal-title":"Eur J Heart Fail."},{"key":"10.1016\/j.rec.2023.06.014_bib0620","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ajh.23898","article-title":"Kinetics of organ response and survival following normalization of the serum free light chain ratio in AL amyloidosis","volume":"90","author":"Kaufman","year":"2015","journal-title":"Am J Hematol."},{"key":"10.1016\/j.rec.2023.06.014_bib0625","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/bmt.2013.53","article-title":"Patients with immunoglobulin light chain amyloidosis undergoing autologous stem cell transplantation have superior outcomes compared with patients with multiple myeloma: a retrospective review from a tertiary referral center","volume":"48","author":"Dispenzieri","year":"2013","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.rec.2023.06.014_bib0630","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1056\/NEJMoa2028631","article-title":"Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis","volume":"385","author":"Kastritis","year":"2021","journal-title":"N Eng J Med."},{"key":"10.1016\/j.rec.2023.06.014_bib0635","first-page":"67","article-title":"Systemic Light Chain Amyloidosis, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology","volume":"21","author":"Kumar","year":"2023","journal-title":"J Natl Compr Canc Netw."},{"key":"10.1016\/j.rec.2023.06.014_bib0640","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2011.37.7614","article-title":"New Criteria for Response to Treatment in Immunoglobulin Light Chain Amyloidosis Based on Free Light Chain Measurement and Cardiac Biomarkers: Impact on Survival Outcomes","volume":"30","author":"Palladini","year":"2012","journal-title":"J Clin Oncol."},{"key":"10.1016\/j.rec.2023.06.014_bib0645","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1161\/CIRCULATIONAHA.122.060852","article-title":"Impact of Earlier Diagnosis in Cardiac ATTR Amyloidosis Over the Course of 20 Years","volume":"146","author":"Ioannou","year":"2022","journal-title":"Circulation."},{"key":"10.1016\/j.rec.2023.06.014_bib0650","doi-asserted-by":"crossref","first-page":"E009025","DOI":"10.1161\/CIRCIMAGING.121.009025","article-title":"Cardiac Amyloidosis: Multimodal Imaging of Disease Activity and Response to Treatment","volume":"14","author":"Patel","year":"2021","journal-title":"Circ Cardiovasc Imaging."},{"key":"10.1016\/j.rec.2023.06.014_bib0655","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s11886-022-01703-7","article-title":"Imaging-Guided Treatment for Cardiac Amyloidosis","volume":"24","author":"Ioannou","year":"2022","journal-title":"Curr Cardiol Rep."},{"key":"10.1016\/j.rec.2023.06.014_bib0660","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1021\/bi0616605","article-title":"Localization of a Conformational Epitope Common to Non-Native and Fibrillar Immunoglobulin Light Chains","volume":"46","author":"O\u2019Nuallain","year":"2007","journal-title":"Biochemistry."},{"key":"10.1016\/j.rec.2023.06.014_bib0665","doi-asserted-by":"crossref","first-page":"e52686","DOI":"10.1371\/journal.pone.0052686","article-title":"AL Amyloid Imaging and Therapy with a Monoclonal Antibody to a Cryptic Epitope on Amyloid Fibrils","volume":"7","author":"Wall","year":"2012","journal-title":"PLoS One."},{"issue":"Suppl 1","key":"10.1016\/j.rec.2023.06.014_bib0670","article-title":"Pre-Clinical Characterization of a Novel Fusion Protein (AT-03), with Pan-Amyloid Binding and Removal","volume":"138","author":"Sirac","year":"2021","journal-title":"Blood."}],"container-title":["Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585723002372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1885585723002372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T11:02:21Z","timestamp":1761822141000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1885585723002372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1885585723002372"],"URL":"https:\/\/doi.org\/10.1016\/j.rec.2023.06.014","relation":{},"ISSN":["1885-5857"],"issn-type":[{"value":"1885-5857","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Monitoring cardiac amyloidosis with multimodality imaging","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Cardiolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rec.2023.06.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.recesp.2023.06.017","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Cardiolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}